Scientific publications 2003

1. Baldeschi, C., Gache, Y., Rattenholl, A., Bouille, P., Danos, O., Ortonne, J.P., Bruckner-Tuderman, L. and Meneguzzi, G.: “Genetic correction of canine dystrophic epidermolysis bullosa mediated by retroviral vectors”. Hum Mol Genet 12 (2003) 1897-905.

2. Brissault, B., Kichler, A., Guis, C., Leborgne, C., Danos, O. and Cheradame, H.: “Synthesis of linear polyethylenimine derivatives for DNA transfection”. Bioconjug Chem 14 (2003) 581-7.

3. Chalouni, C., Banchereau, J., Vogt, A.B., Pascual, V. and Davoust, J.: “Human germinal center B cells differ from naive and memory B cells by their aggregated MHC class II-rich compartments lacking HLA-DO”. Int Immunol 15 (2003) 457-66.

4. Chantret, I., Dancourt, J., Dupre, T., Delenda, C., Bucher, S., Vuillaumier-Barrot, S., Ogier de Baulny, H., Peletan, C., Danos, O., Seta, N., Durand, G., Oriol, R., Codogno, P. and Moore, S.E.: “A deficiency in dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolichyl alpha3-glucosyltransferase defines a new subtype of congenital disorders of glycosylation”. J Biol Chem 278 (2003) 9962-71.

5. Chaouch, M., Allal, Y., De Sandre-Giovannoli, A., Vallat, J.M., Amer-el-Khedoud, A., Kassouri, N., Chaouch, A., Sindou, P., Hammadouche, T., Tazir, M., Levy, N. and Grid, D.: “The phenotypic manifestations of autosomal recessive axonal Charcot-Marie-Tooth due to a mutation in Lamin A/C gene”. Neuromuscul Disord 13 (2003) 60-7.

6. Coeytaux, E., Coulaud, D., Le Cam, E., Danos, O. and Kichler, A.: “The cationic amphipathic alpha-helix of HIV-1 Viral protein R (Vpr) binds to nucleic acids, permeabilizes membranes, and efficiently transfects cells”. J Biol Chem 278 (2003) 18110-18116.

7. Combaret, L., Bechet, D., Claustre, A., Taillandier, D., Richard, I. and Attaix, D.: “Down-regulation of genes in the lysosomal and ubiquitin-proteasome proteolytic pathways in calpain-3-deficient muscle”. Int J Biochem Cell Biol 35 (2003) 676-84.

8. De Sandre-Giovannoli, A., Chaouch, M., Boccaccio, I., Bernard, R., Delague, V., Grid, D., Vallat, J.M., Levy, N. and Megarbane, A.:“Phenotypic and genetic exploration of severe demyelinating and secondary axonal neuropathies resulting from GDAP1 nonsense and splicing mutations”. J Med Genet 40 (2003) e87.

9. Douar, A.M., Poulard, K. and Danos, O.: “Deleterious effect of peptide insertions in a permissive site of the AAV2 capsid”. Virology 309 (2003) 203-8.

10. Fougerousse, F., Gonin, P., Durand, M., Richard, I. and Raymackers, J.M.: “Force impairment in calpain 3-deficient mice is not correlated with mechanical disruption”. Muscle Nerve 27 (2003) 616-623.

11. Fruci, D., Lauvau, G., Saveanu, L., Amicosante, M., Butler, R.H., Polack, A., Ginhoux, F., Lemonnier, F., Firat, H. and van Endert, P.M.:“Quantifying recruitment of cytosolic peptides for HLA class I presentation: impact of TAP transport”. J Immunol 170 (2003) 2977-84.

12. Ginhoux, F., Doucet, C., Leboeuf, M., Lemonnier, F.A., Danos, O., Davoust, J. and Firat, H.: “Identification of an HLA-A*0201-restricted epitopic peptide from human dystrophin: application in duchenne muscular dystrophy gene therapy”. Mol Ther 8 (2003) 274-83.

13. Gross, D.A., Leboeuf, M., Gjata, B., Danos, O. and Davoust, J.: “CD4+CD25+ regulatory T cells inhibit immune mediated transgene rejection”. Blood 102 (2003) 4326-4328.

14. Guermonprez, P., Saveanu, L., Kleijmeer, M., Davoust, J., Van Endert, P. and Amigorena, S.: “ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells”. Nature 425 (2003) 397-402.

15. Jobard, F., Bouadjar, B., Caux, F., Hadj-Rabia, S., Has, C., Matsuda, F., Weissenbach, J., Lathrop, M., Prud’homme, J.F. and Fischer, J.:“Identification of mutations in a new gene encoding a FERM family protein with a pleckstrin homology domain in Kindler syndrome”. Hum Mol Genet 12 (2003) 925-35.

16. Karsenty, E., Barillot, E., Tosser-Klopp, G., Lahbib-Mansais, Y., Milan, D., Hatey, F., Cirera, S., Sawera, M., Jorgensen, C.B., Chowdhary, B., Fredholm, M., Wimmers, K., Ponsuksili, S., Davoli, R., Fontanesi, L., Braglia, S., Zambonelli, P., Bigi, D., Neuenschwander, S. and Gellin, J.L.: “The GENETPIG database: a tool for comparative mapping in pig (Sus scrofa)”. Nucleic Acids Research 31 (2003) 138-141.

17. Kichler, A., Bechinger, B. and Danos, O.: “Des peptides cationiques antibactériens comme vecteurs de transfert de gènes”. Med Sci (Paris) 19 (2003) 1046-47.

18. Kichler, A., Leborgne, C., März, J., Danos, O. and Bechinger, B.: “Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells”. Proc Natl Acad Sci USA 100 (2003) 1564-1568.

19. Kichler, A., Sabourault, N., Decor, R., Leborgne, C., Schmutz, M., Valleix, A., Danos, O., Wagner, A. and Mioskowski, C.: “Preparation and evaluation of a new class of gene transfer reagents: poly(-alkylaminosiloxanes)”. J Control Release 93 (2003) 403-14.

20. Laderach, D., Compagno, D., Danos, O., Vainchenker, W. and Galy, A.: “RNA Interference Shows Critical Requirement for NF-kappaB p50 in the Production of IL-12 by Human Dendritic Cells”. J Immunol 171 (2003) 1750-7.

21. Lefèvre, C., Audebert, S., Jobard, F., Bouadjar, B., Lakhdar, H., Boughdene-Stambouli, O., Blanchet-Bardon, C., Heilig, R., Foglio, M., Weissenbach, J., Lathrop, M., Prud’homme, J.F. and Fischer, J.: “Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2”. Hum Mol Genet 12 (2003) 2369-78.

22. Marchand, S., Hajdari, P., Hackman, P., Udd, B. and Richard, I.: “Touch-down method for high-performance sequencing of polymerase chain reaction products”. Anal Biochem 315 (2003) 270-2.

23. Marrakchi, S., Audebert, S., Bouadjar, B., Has, C., Lefevre, C., Munro, C., Cure, S., Jobard, F., Morlot, S., Hohl, D., Prud’homme, J.F., Zahaf, A., Turki, H. and Fischer, J.: “Novel mutations in the gene encoding secreted lymphocyte antigen-6/urokinase-type plasminogen activator receptor-related protein-1 (SLURP-1) and description of five ancestral haplotypes in patients with Mal de Meleda”. J Invest Dermatol 120 (2003) 351-5.

24. Merten, O.-W.: “Métabolisme cellulaire et besoin nutritif des cellules en culture”. In: Barlovatz-Meinon, G. and Adolphe, M. (Eds.), Techniques en Cultures de cellules animales: méthodologies, applications. Les Editions Inserm, Paris, 2003, pp. 99-160.

25. Merten, O.-W. and Audit, M.: “Gene therapy: General safety tests and vector specific safety issues”, Standardisation and Quality Control – Cell and Gene Therapy Products. EDQM – Council of Europe, Strasbourg/France, 2003.

26. Nabbout, R., Gennaro, E., Dalla Bernardina, B., Dulac, O., Madia, F., Bertini, E., Capovilla, G., Chiron, C., Cristofori, G., Elia, M., Fontana, E., Gaggero, R., Granata, T., Guerrini, R., Loi, M., La Selva, L., Lispi, M.L., Matricardi, A., Romeo, A., Tzolas, V., Valseriati, D., Veggiotti, P., Vigevano, F., Vallee, L., Dagna Bricarelli, F., Bianchi, A. and Zara, F.: “Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy”. Neurology 60 (2003) 1961-7.

27. Nabbout, R., Kozlovski, A., Gennaro, E., Bahi-Buisson, N., Zara, F., Chiron, C., Bianchi, A., Brice, A., Leguern, E. and Dulac, O.:“Absence of mutations in major GEFS+ genes in myoclonic astatic epilepsy”. Epilepsy Res 56 (2003) 127-33.

28. Pagès, J.C. and Danos, O.: “Retrovectors go forward”. In: Rolland, A. and Sullivan, S.M. (Eds.), Pharmaceutical Gene Delivery Systems. Marcel Dekker, Inc, Basel, 2003, pp. 215-244.

29. Rohrlich, P.S., Cardinaud, S., Firat, H., Lamari, M., Briand, P., Escriou, N. and Lemonnier, F.A.: “HLA-B*0702 transgenic, H-2K(b)D(b) double-knockout mice: phenotypical and functional characterization in response to influenza virus”. Int Immunol 15 (2003) 765-772.

30. Sander, T., Windemuth, C., Schulz, H., Saar, K., Gennaro, E., Riggio, C., Bianchi, A., Zara, F., Rudolf, G., Picard, F., Bulteau, C., Kaminska, A., Cieuta, C., Prud’homme, J.F., Dulac, O., Bate, L., Robinson, R., Gardiner, R.M., Covanis, A., De Haan, G.J., Janssen, G.A., Van Erp, M.G., Boezeman, E.H., Lindhout, D., Heils, A., Nurnberg, P. and Janz, D.: “Exploration of a putative susceptibility locus for idiopathic generalized epilepsy on chromosome 8p12”. Epilepsia 44 (2003) 32-9.

31. Sandre-Giovannoli, A.D., Chaouch, M., Boccaccio, I., Bernard, R., Delague, V., Grid, D., Vallat, J.M., Levy, N. and Megarbane, A.:“Phenotypic and genetic exploration of severe demyelinating and secondary axonal neuropathies resulting from GDAP1 nonsense and splicing mutations”. Journal Of Medical Genetics 40 (2003).

32. Scardino, A., Correale, P., Firat, H., Pellegrini, M., Kosmatopoulos, K., Opolon, P., Alves, P., Zurbriggen, R., Gluck, R., Lemonnier, F.A., Francini, G. and Cusi, M.G.: “In vivo study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouse”. Br J Cancer 89 (2003) 199-205.

33. Seifert, U., Maranon, C., Shmueli, A., Desoutter, J.F., Wesoloski, L., Janek, K., Henklein, P., Diescher, S., Andrieu, M., de la Salle, H., Weinschenk, T., Schild, H., Laderach, D., Galy, A., Haas, G., Kloetzel, P.M., Reiss, Y. and Hosmalin, A.: “An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope”. Nat Immunol 4 (2003) 375-9.

34. Stumptner-Cuvelette, P., Jouve, M., Helft, J., Dugast, M., Glouzman, A.S., Jooss, K., Raposo, G. and Benaroch, P.: “Human immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: potential role of phosphatidylinositol 3-kinase”. Mol Biol Cell 14 (2003) 4857-70.

35. Taveau, M., Bourg, N., Sillon, G., Roudaut, C., Bartoli, M. and Richard, I.: “Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components”. Mol Cell Biol 23 (2003) 9127-35.

36. Van Den Bergh, P.Y., Bouquiaux, O., Verellen, C., Marchand, S., Richard, I., Hackman, P. and Udd, B.: “Tibial muscular dystrophy in a Belgian family”. Ann Neurol 54 (2003) 248-51.